Tro Kalayjian is a medical school student, contract consultant, and contributing writer.
Contributing Writer: Seeking Alpha, BioMedReports.com, ThreeBrothersHealth.com
Contract Consulting: Provide initial due diligence and quarterly updates: Biotechnology, Pharmaceuticals, Drug delivery, Drug discovery
Education: Medicine (expected 2011), Health Science, Finance (2005)
The material, information and facts discussed in articles or posts published by this author on Seeking Alpha, Yahoo Financial News, Google News, Google Finance, Yahoo Message Boards, ThreeBrothersHealth.com, or BioMedReports are sources believed to be reliable, but are in no way guaranteed to be complete or accurate. Posts and articles should not be used as a complete analysis of the company, industry or security discussed. Additional information is available upon request. This is not, however, an offer or solicitation of the securities discussed. Any opinions or estimates in articles or posts are subject to change without notice. An investment in any stocks may involve risk and uncertainty that could cause actual results to differ materially from the forward-looking statements. Additionally, an investment in stocks may involve a high degree of risk and may not be suitable for all investors. No part of any article, comment or posts may be reproduced in any form without the express written permission of ThreeBrothersHealth.com
See Seeking Alpha's policy on anonymous authors.